| خلاصه مقاله | Background: Obesity is reaching epidemic proportions worldwide and correlated
with various comorbidities such as diabetes mellitus, fatty liver and cardiovascular
diseases. Diabetes and obesity are combined with such frequency that it has been
proposed for the term Diabesity. Carnitine in high doses has no side effects of other
anti-obesity drugs. In this regard, we evaluated the effect of l-carnitine supplementation
on serum leptin and visfatin levels (that almost are secreted from central and
peripheral fat respectively) as markers of endothelial dysfunction.
Methods and Materials: In this clinical trial, 32 obese men suffering type II diabetes
with a BMI greater than 25 were randomly selected and divided into two groups.
After measuring the weight, waist circumference and record the personal details of
patients, their information about three-day food records were down in sheets. During
the 10 week intervention group complement of L - carnitine (1.5 g/ day) with lowcalorie
diet and the second group received placebo plus low-calorie diet.
Results: Supplementation of carnitine with low calorie diet reduces anthropometric
indices, serum level of leptin, visfatin and inflammatory markers (p <0.0001),
whereas the reduction in mentioned factors in controls was significant, but lower than
case group.
Conclusion: L-carnitine supplementation has pronounced and more significant impact
on levels of leptin, visfatin, inflammatory markers and anthropometric indices,
especially Adiposity (abdominal fat) in patients. |